关注
Athira R Nair
Athira R Nair
Assistant Professor - Senior Scale, Dept. of Pharmaceutical Quality Assurance, MAHE
在 manipal.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Overview of extensively employed polymeric carriers in solid dispersion technology
AR Nair, YD Lakshman, VSK Anand, KSN Sree, K Bhat, SJ Dengale
AAPS PharmSciTech 21, 1-20, 2020
1222020
Considerations for the selection of co-formers in the preparation of co-amorphous formulations
DL Yarlagadda, VSK Anand, AR Nair, KSN Sree, SJ Dengale, K Bhat
International Journal of Pharmaceutics 602, 120649, 2021
392021
Influence of preparation methods on physicochemical and pharmacokinetic properties of co-amorphous formulations: The case of co-amorphous atorvastatin: Naringin
A Nair, R Varma, K Gourishetti, K Bhat, S Dengale
Journal of Pharmaceutical Innovation 15, 365-379, 2020
352020
The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials
VSK Anand, SD Sakhare, KSN Sree, AR Nair, KR Varma, K Gourishetti, ...
European Journal of Pharmaceutical Sciences 123, 124-134, 2018
292018
Polymeric solid dispersion Vs co-amorphous technology: A critical comparison
SKA Vullendula, AR Nair, DL Yarlagadda, KSN Sree, K Bhat, SJ Dengale
Journal of Drug Delivery Science and Technology 78, 103980, 2022
92022
A computational-based approach to fabricate Ceritinib co-amorphous system using a novel co-former Rutin for bioavailability enhancement
DL Yarlagadda, VSK Anand, AR Nair, SJ Dengale, S Pandiyan, ...
European Journal of Pharmaceutics and Biopharmaceutics 190, 220-230, 2023
52023
Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion: an in-vitro and ex-vivo investigation
AR Nair, SKA Vullendula, DL Yarlagadda, B Bheemisetty, SJ Dengale, ...
Drug Development and Industrial Pharmacy 50 (3), 192-205, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–7